Philadelphia, Pennsylvania--(Newsfile Corp. - November 13, 2024) - Have You Held Inari Medical Shares Continuously Since Before February 24, 2022? Learn More About Your Rights at No Cost to You. Visit https://grabarlaw.com/the-latest/inari-shareholder-investigation/or contact Joshua H. Grabar at jgrabar@grabarlaw.com or call 267-507-6085.
Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors at Inari Medical, Inc. (NASDAQ: NARI) on behalf of long-term investors. If you have held Inari shares since prior to February 24, 2022, you can seek:
- Corporate reforms to protect your investment.
- Reimbursement of funds expended in litigation back to the company.
- A court-approved incentive award-all at no cost to you.
Why Is Inari Medical Under Investigation?
A recently filed securities fraud class action complaint alleges the following misconduct by Inari's officers and directors:
- Touting misleading "record revenue" claims, attributing growth to the strength of its core VTE business.
- Failing to disclose that significant business expenses were used to improperly compensate medical professionals for using Inari products.
- Concealing an investigation by the U.S. Department of Justice for violations of the Anti-Kickback Statute and Civil False Claims Act.
- Misleading investors about business expenses to hide improper conduct and maintain inflated stock prices.
Take Action Today: Protect Your Investment
If you have held Inari shares since prior to February 24, 2022, learn more about your rights and potential benefits. Visit:
https://grabarlaw.com/the-latest/inari-shareholder-investigation/ or contact Joshua GrabarEmail:jgrabar@grabarlaw.com - Phone: 267-507-6085
#InariMedical #NARI $NARI #SecuritiesFraud #InvestorRights #ShareholderAlert #CorporateGovernance #FiduciaryDuty #ClassAction #GrabarLaw #LegalAction #StockMarket
Attorney Advertising Disclaimer
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229811
